United States Últimas notícias

SUNation Energy (NASDAQ:SUNE) and Suniva announced on June 8, 2026, the signing of a definitive reverse merger agreement.

Graham (NYSE:GHM) announced its financial results for the fourth quarter and full fiscal year ended March 31, 2026, marking a period of record-setting performance for the Batavia, New York-based manufacturer.

AECOM (NYSE:ACM) announced today that it has been awarded a new contract to provide comprehensive architecture and engineering (A/E) services to the U.S. Department of Homeland Security (DHS).

Pfizer (NYSE:PFE) announced on June 8, 2026, that the U.S. Food and Drug Administration (FDA) has granted an expanded indication for HYMPAVZI® (marstacimab-hncq). The therapy is now approved for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and pediatric patients 6 years of age and older with hemophilia A or B, both with and without inhibitors.

Aeries Technology (NASDAQ:AERT) announced its financial results for the fiscal year ended March 31, 2026, marking a pivotal year of transformation.

AstroNova (NASDAQ:ALOT), a global leader in specialized print technology solutions, reported financial results for its fiscal 2027 first quarter ended April 30, 2026.

Lyell Immunopharma (NASDAQ:LYEL) announced on Monday that it has amended its ongoing U.S. Phase 1 clinical trial for LYL273 to a Phase 1/2 design.

US stocks have staged a modest rebound even as flaring tensions in the Middle East sent oil prices and bond yields higher. Futures for the S&P 500 rose 0.2% after a selloff in artificial intelligence stocks came to a halt. Bond traders are wagering that inflation figures this week will show the biggest surge in consumer prices in several years, adding to pressure on the Federal Reserve to raise interest rates. Global bond markets have seen a profound shift since late February, when the US and Israel's attacks on Iran sparked a surge in oil prices, derailing bets that the central bank was poised to lower rates in 2026. Lindsay Rosner, Head of Multi-Sector Investing at Goldman Sachs Asset Management explains.

Shattuck Labs (NASDAQ:STTK) announced positive top-line results from its Phase 1 clinical trial of SL-325, a novel Death Receptor 3 (DR3) blocking antibody.

Honeywell International (NASDAQ:HON) announced on Monday that it is reaffirming its full-year 2026 financial guidance as the company nears the final stages of its portfolio transformation.

Brookfield Head of AI Infrastructure and Head of Europe Sikander Rashid joins Bloomberg's Tom Mackenzie to kick off London Tech Week as part of Bloomberg Brief.

Brookfield Head of AI Infrastructure and Head of Europe Sikander Rashid joins Bloomberg's Tom Mackenzie to kick off London Tech Week as part of Bloomberg Brief.